BridgeMD
Route of nutrition and muscle wasting after oesophagectomy
EU CTIS ID: 2023-507649-27-00
What this study is testing
To elucidate how route of nutrition impacts cachexia after oesophagostomy
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Scheduled for elective oesophagectomy at the Department of Thoracic Surgery, Aarhus University Hospital. Included procedures: Oesophagectomy (scopic procedure) with gastric pull-up. Distal oesophagectomy with total gastrectomy and other reconstructive procedures (duodenum or colon) Total oesophagectomy with colon anastomosis in the neck area. Eligible for both enteral and TPN. Age ≥ 18 years
You likely can't join if
- Lack of consent Women of childbearing age without negative pregnancy test Known allergy or intolerance to any of the included drugs Diagnosed with primary skeletal muscle disease that could influence muscle wasting according to the investigator
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.